Stem Cell Injection Therapy

At Dr. Goldbaum’s offices, new and exciting regenerative medical treatments are currently being used to treat patients suffering from a wide variety of soft tissue disorders of the lower extremities such as plantar fasciitis and Achilles tendonitis.

One of these cutting-edge treatments is known as amniotic stem cell injection therapy, which harnesses your body’s natural potential to regenerate tissue and return to a pre-wound, healthy state.

For over a century, amniotic tissue has been used in a broad range of therapeutic applications. It has been generally recognized as an effective modality in advancing treatment of soft tissue defects, soft tissue trauma, tendonitis, tendonosis, chronic wounds, and localized inflammation.

In short, stem cell treatment takes advantage of your body’s ability to repair itself.

While other drugs typically only provide temporary pain relief, stem cells actually restore your degenerated tissue while also providing pain relief. Additionally, stem cell injections also contain hyaluronic acid, which lubricates your joints and tendons, easing the pain and helping restore mobility.

A very safe and effective treatment, Dr. Goldbaum is able to inject stem cells from amniotic tissues into your body using ultrasound guidance in process that typically takes only five minutes. These stem cells have anti-inflammatory properties, similar to cortisone and steroid shots, but are far more effective since they tackle the problem directly at its source.

When considering your treatment options, amniotic stem cell therapy is a preferred type of stem cell therapy because the cells come from an immunoprivileged site, which means that patient rejection is extremely rare. In fact, a recent study showed that more than 10,000 injections have been performed without a single reported adverse side effect.

The use of amniotic stem cells is well researched, safe, and effective. All amniotic stem cell donors go through a rigorous screening process, as determined by the Food and Drug Administration (FDA) and American Association of Tissue Banks (AATB).